Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,176,441
  • Shares Outstanding, K 73,845
  • Annual Sales, $ 1,840 M
  • Annual Income, $ 241,700 K
  • 60-Month Beta 0.95
  • Price/Sales 6.25
  • Price/Cash Flow 33.10
  • Price/Book 7.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.83
  • Number of Estimates 4
  • High Estimate 0.87
  • Low Estimate 0.79
  • Prior Year 0.74
  • Growth Rate Est. (year over year) +12.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
124.53 +26.41%
on 03/23/20
159.83 -1.51%
on 03/31/20
+7.47 (+4.98%)
since 03/06/20
3-Month
124.53 +26.41%
on 03/23/20
176.66 -10.89%
on 02/19/20
+5.20 (+3.42%)
since 01/06/20
52-Week
109.88 +43.27%
on 04/18/19
176.66 -10.89%
on 02/19/20
+44.55 (+39.47%)
since 04/05/19

Most Recent Stories

More News
The Global Analytical Laboratory Services Market is expected to grow from USD 598.37 Million in 2018 to USD 1,334.37 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.13%

Reportlinker.com announces the release of the report "Global Analytical Laboratory Services Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts...

WST : 156.72 (+3.55%)
Here's Why You Should Invest in DaVita (DVA) Stock Right Now

DaVita (DVA) continues to gain traction from strong international foothold, strategic buyout of dialysis centers and DaVita Kidney Care.

ARAY : 1.8600 (+7.51%)
DVA : 70.15 (+7.07%)
COO : 291.59 (+4.26%)
WST : 156.72 (+3.55%)
Here's Why You Should Retain Merit Medical (MMSI) Stock Now

Merit Medical (MMSI) continues to benefit from growing product pipeline, strong R&D focus and strategic acquisitions.

ARAY : 1.8600 (+7.51%)
MMSI : 32.85 (+8.02%)
COO : 291.59 (+4.26%)
WST : 156.72 (+3.55%)
Shares of Haemonetics Corp Rank the Highest in Terms of Relative Performance in the Health Care Supplies Industry (HAE , QDEL , WST , XRAY , COO )

We looked at the Health Care Supplies industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

HAE : 101.59 (+3.24%)
QDEL : 94.81 (-0.20%)
WST : 156.72 (+3.55%)
Here's Why You Should Hold on to NextGen Healthcare Stock Now

NextGen Healthcare (NXGN) continues to benefit from growing RCM and EHR markets, and robust demand for other NextGen solutions.

ARAY : 1.8600 (+7.51%)
COO : 291.59 (+4.26%)
WST : 156.72 (+3.55%)
NXGN : 9.50 (+3.26%)
Orasure Tech has the Best Relative Performance in the Health Care Supplies Industry (OSUR , WST , STAA , QDEL , VIVO )

We looked at the Health Care Supplies industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We...

OSUR : 10.95 (+6.21%)
STAA : 32.48 (+11.42%)
WST : 156.72 (+3.55%)
Here's Why You Should Retain Cerner (CERN) Stock for Now

Cerner (CERN) is gaining traction from prudent strategic deals and big data based EHR system. However, weak margin remains a woe.

ARAY : 1.8600 (+7.51%)
CERN : 63.14 (+1.40%)
COO : 291.59 (+4.26%)
WST : 156.72 (+3.55%)
NextGen's New Platform Set to Improve Patient Engagement

The availability of NextGen's (NXGN) Patient Experience Platform is likely to enable high-quality healthcare and drive patient engagement.

ARAY : 1.8600 (+7.51%)
COO : 291.59 (+4.26%)
WST : 156.72 (+3.55%)
NXGN : 9.50 (+3.26%)
SmarTrend Watching for Potential Rebound in Shares of West Pharmaceut After 4.43% Loss

West Pharmaceut (NYSE:WST) traded in a range yesterday that spanned from a low of $136.27 to a high of $147.79. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $136.65...

WST : 156.72 (+3.55%)
Buy These 5 Low Leverage Stocks Amid Coronavirus Outbreak

Higher debt financing is never desirable. So, an investor's portfolio should include stocks that are not highly leveraged.

DECK : 135.80 (+11.21%)
COST : 302.44 (+4.78%)
PFG : 27.93 (+5.76%)
WST : 156.72 (+3.55%)
WNS : 38.26 (+3.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade WST with:

Business Summary

West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines...

See More

Key Turning Points

2nd Resistance Point 159.19
1st Resistance Point 155.27
Last Price 156.72
1st Support Level 148.58
2nd Support Level 145.80

See More

52-Week High 176.66
Last Price 156.72
Fibonacci 61.8% 151.15
Fibonacci 50% 143.27
Fibonacci 38.2% 135.39
52-Week Low 109.88

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar